SILVER SPRING
Linzess cleared for pediatric functional constipation
- Sponsor
- Ironwood Pharmaceuticals $IRWD
- Drug
- Linzess · linaclotide
- Indication
- Functional constipation
FDA approved Linzess (linaclotide) for pediatric patients aged 2+ with functional constipation.
What this means
Linzess is a capsule that helps relieve constipation by increasing fluid in the intestines and speeding up bowel movements. FDA has now approved Linzess for children aged 2 and older who have functional constipation, a condition where bowel movements are infrequent or difficult without a clear cause. This decision gives pediatricians and families a new treatment option, though parents should watch for signs of dehydration, a known risk in children taking the drug.